Consistently, mutations found in ALK2 of patients suffering from the heterotopic ossification disease FOP (Fibrodysplasia ossificans progressiva) are assumed to destabilize the inactive state leading to a (partially) activated ALK2 receptor kinase [102,104]. Here, ACVR1 is linked to fibrodysplasia ossificans progressiva.